281 related articles for article (PubMed ID: 19553086)
21. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of antipsychotics in early onset psychoses: a long-term comparison.
Cianchetti C; Ledda MG
Psychiatry Res; 2011 Oct; 189(3):349-56. PubMed ID: 21570128
[TBL] [Abstract][Full Text] [Related]
24. Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo.
Stauffer VL; Millen BA; Andersen S; Kinon BJ; Lagrandeur L; Lindenmayer JP; Gomez JC
Schizophr Res; 2013 Nov; 150(2-3):434-41. PubMed ID: 24035403
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary.
Bitter I; Katona L; Zámbori J; Takács P; Fehér L; Diels J; Bacskai M; Lang Z; Gyáni G; Czobor P
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1383-90. PubMed ID: 23477752
[TBL] [Abstract][Full Text] [Related]
26. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
Matsuda Y; Sato S; Iwata K; Furukawa S; Hatsuse N; Watanabe Y; Anzai N; Kishimoto T; Ikebuchi E
Psychiatry Clin Neurosci; 2014 Jun; 68(6):425-31. PubMed ID: 24506576
[TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
[TBL] [Abstract][Full Text] [Related]
28. Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
Hattori S; Kishida I; Suda A; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
Schizophr Res; 2018 Mar; 193():134-138. PubMed ID: 28709776
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol.
Parabiaghi A; Tettamanti M; D'Avanzo B; Barbato A;
Acta Psychiatr Scand; 2016 Jan; 133(1):63-75. PubMed ID: 26252780
[TBL] [Abstract][Full Text] [Related]
30. A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.
Kumar P B S; Pandey RS; Thirthalli J; Kumar P T S; Kumar C N
Curr Neuropharmacol; 2017 Nov; 15(8):1073-1084. PubMed ID: 28088913
[TBL] [Abstract][Full Text] [Related]
31. Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia.
Ishigooka J; Nakagome K; Ohmori T; Iwata N
BMC Psychiatry; 2013 Oct; 13():243. PubMed ID: 24090047
[TBL] [Abstract][Full Text] [Related]
32. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia.
Buoli M; Kahn RS; Serati M; Altamura AC; Cahn W
Hum Psychopharmacol; 2016 Jul; 31(4):325-31. PubMed ID: 27297936
[TBL] [Abstract][Full Text] [Related]
33. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.
Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J;
Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548
[TBL] [Abstract][Full Text] [Related]
34. All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis.
Beasley CM; Stauffer VL; Liu-Seifert H; Taylor CC; Dunayevich E; Davis JM
J Clin Psychopharmacol; 2007 Jun; 27(3):252-8. PubMed ID: 17502771
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.
Patel JK; Buckley PF; Woolson S; Hamer RM; McEvoy JP; Perkins DO; Lieberman JA;
Schizophr Res; 2009 Jun; 111(1-3):9-16. PubMed ID: 19398192
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.
Varimo E; Aronen ET; Mogk H; Rättö H; Saastamoinen LK
J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):421-429. PubMed ID: 33739863
[No Abstract] [Full Text] [Related]
37. Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Ortiz V; Pelayo-Terán JM; Valdizan E; Vazquez-Barquero JL
Psychopharmacology (Berl); 2012 Jan; 219(1):225-33. PubMed ID: 21735072
[TBL] [Abstract][Full Text] [Related]
38. A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Hatta K; Otachi T; Sudo Y; Kuga H; Takebayashi H; Hayashi H; Ishii R; Kasuya M; Hayakawa T; Morikawa F; Hata K; Nakamura M; Usui C; Nakamura H; Hirata T; Sawa Y;
Psychiatry Res; 2012 Jul; 198(2):194-201. PubMed ID: 22421064
[TBL] [Abstract][Full Text] [Related]
39. Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.
Pozzi M; Pisano S; Bertella S; Capuano A; Rizzo R; Antoniazzi S; Auricchio F; Carnovale C; Cattaneo D; Ferrajolo C; Gentili M; Guastella G; Mani E; Rafaniello C; Riccio MP; Scuderi MG; Sperandeo S; Sportiello L; Villa L; Radice S; Clementi E; Rossi F; Pascotto A; Bernardini R; Molteni M; Bravaccio C
J Clin Psychiatry; 2016 Dec; 77(12):e1601-e1609. PubMed ID: 27780333
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
